Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06262165
Status:
RECRUITING
Last Update Posted:
2024-04-12
First Post:
2024-01-29
Brief Title:
Evaluation of Liver Damage in Patients With Anorexia Nervosa by Blood Biomarker Analysis
Sponsor:
Nantes University Hospital
Organization:
Nantes University Hospital
Study Overview
Official Title:
BILAN Evaluation of Liver Damage in Patients With Anorexia Nervosa by Blood BIomarker ANaLysis
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BILAN
Brief Summary:
The main goal of the BIocoLlection in Anorexia Nervosa-liver damage evaluation BILAN study the blood biomarkers associated with liver cytolysis
Detailed Description:
Study of the association between blood biomarkers and the presence of hepatic cytolysis defined by AST andor ALT above normal
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None